Rheumatoid Arthritis
Conditions
Keywords
Rheumatoid hand, Fluidotherapy, Rehabilitation
Brief summary
The objective of this study is to evaluate the efficacy of fluidotherapy primarily on function and quality of life, secondarily on pain, morning stiffness, grip strength, and disease activity in patients with rheumatoid hand.Ninety-three patients were enrolled in this prospective, single-blind, randomized, and controlled trial. Patients were randomized into 2 groups. Group 1 (n=47) had fluidotherapy (5 times per week, for 3-week duration) and Group 2 (n=46) was the control group. All patients received joint protection and exercise program. The primary outcome measures were Health Assessment Questionnaire (HAQ) and Duruöz Hand Index (DHI) and secondary outcome measures were pain and morning stiffness assessed using the Visual Analog Scale (VAS, 0-100 mm), the Grip Ability Test (GAT), Disease Activity Score-28 (DAS-28), and grip strength. These assessments were performed at baseline, at week 3 and week 12 after treatment.
Interventions
OTHERFluidotherapy treatment
fluidotherapy and joint protection and exercise
OTHERJoint protection and exercise
joint protection and exercise
Sponsors
Selmin Gulbahar
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)
Eligibility
Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No
Inclusion criteria
* age between 18-75 years RA diagnosis fulfilling ACR 2010 criteria * disease duration for at least 6 months * no high disease activity and no acute arthritis in the hand according to DAS-28 * hand problem specified with pain and loss of function in the hand * being in an eligible sociocultural and socioeconomic state so as to be able to come to the ambulatory treatment program
Exclusion criteria
* change of medication within the last 3 months or during the study (except for non-steroidal anti-inflammatory drugs and paracetamol) * changes in oral corticosteroid dose in the last month, intraarticular or intramuscular corticosteroid use * hand or upper extremity surgery in the last 6 months * previous injury in the hand or upper extremity in the last 6 months * pregnancy * presence of sensory defects in the hand * presence of cognitive and/or psychiatric disease * physical therapy for the hand in the last 3 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Health Assessment Questionnaire (HAQ) | Change from Baseline, Health Assessment Questionnaire score at 3 weeks and 12 weeks |
| Duruöz Hand Index (DHI) | Change from Baseline. Duruöz Hand Index score at 3 weeks and 12 weeks |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Grip Ability Test (GAT) | baseline, at week 3 and week 12 | — |
| pain | baseline, at week 3 and week 12 | Visual Analog Scale (VAS, 0-100 mm) |
| grip strength | baseline, at week 3 and week 12 | Jamar measure |
| Disease Activity Score-28 (DAS-28) | baseline, at week 3 and week 12 | — |
| stiffness | baseline, at week 3 and week 12 | Visual Analog Scale (VAS, 0-100 mm) |
Outcome results
None listed